Study in Patients With COPD

Completed · Phase 2

Conditions studied: COPD

In brief

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective compared to the control drug.

Key facts

Study ID

NCT00215384

Run by

Dey

People needed

35

Expected to finish

2005-10-01

Last updated by the study team

2010-11-11

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of COPD and cigarette smoking

You may not qualify if…

• Clinical diagnosis of asthma.
• Chest X-ray that is diagnostic of a significant pulmonary disease other than COPD
• Disease of other major organ systems

Where it is running

• Research Site — Los Angeles, California, United States
• Research Site — Upland, California, United States
• Research Site — Denver, Colorado, United States
• Research Site — Hines, Illinois, United States
• Research Site — Missoula, Montana, United States
• Research Site — Medford, Oregon, United States
• Research Site — Tacoma, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.